Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NTX-301
i
Other names:
NTX-301, AST-081, XNTR-20-02
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Aston Sci., Korea University, PinotBio
Drug class:
DNMT inhibitor
Related drugs:
‹
azacitidine (75)
decitabine (40)
decitabine/cedazuridine (10)
azacitidine oral (7)
OR-2100 (0)
ASTX030 (0)
SGI-110 (0)
azacitidine (75)
decitabine (40)
decitabine/cedazuridine (10)
azacitidine oral (7)
OR-2100 (0)
ASTX030 (0)
SGI-110 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Acute Myelogenous Leukemia
TP53 mutation
Acute Myelogenous Leukemia
venetoclax + NTX-301
Sensitive: D – Preclinical
venetoclax + NTX-301
Sensitive
:
D
venetoclax + NTX-301
Sensitive: D – Preclinical
venetoclax + NTX-301
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.